Vanguard Group Inc. Acquires 136,744 Shares of Patheon N.V. (PTHN)
Vanguard Group Inc. lifted its holdings in Patheon N.V. (NYSE:PTHN) by 306.2% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 181,400 shares of the company’s stock after buying an additional 136,744 shares during the quarter. Vanguard Group Inc. owned approximately 0.12% of Patheon worth $6,327,000 as of its most recent filing with the SEC.
Several other institutional investors have also bought and sold shares of PTHN. Geode Capital Management LLC lifted its position in Patheon by 20.9% in the 1st quarter. Geode Capital Management LLC now owns 47,625 shares of the company’s stock valued at $1,254,000 after purchasing an additional 8,227 shares during the last quarter. Alpine Associates Management Inc. bought a new stake in Patheon in the 2nd quarter valued at about $35,624,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS bought a new stake in Patheon in the 2nd quarter valued at about $12,457,000. Goldman Sachs Group Inc. lifted its position in Patheon by 48.4% in the 1st quarter. Goldman Sachs Group Inc. now owns 100,293 shares of the company’s stock valued at $2,642,000 after purchasing an additional 32,718 shares during the last quarter. Finally, Eaton Vance Management bought a new stake in shares of Patheon during the 2nd quarter worth about $7,394,000. Institutional investors own 0.75% of the company’s stock.
Separately, BidaskClub downgraded shares of Patheon from a “sell” rating to a “strong sell” rating in a research report on Saturday, September 2nd. One analyst has rated the stock with a sell rating, six have given a hold rating and one has given a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $33.60.
Patheon N.V. (NYSE:PTHN) remained flat at $$34.98 during mid-day trading on Wednesday. The stock had a trading volume of 229,700 shares, compared to its average volume of 754,718. Patheon N.V. has a 12 month low of $23.72 and a 12 month high of $35.13. The company has a market capitalization of $5,080.00 and a P/E ratio of 45.43. The company has a current ratio of 1.65, a quick ratio of 0.91 and a debt-to-equity ratio of -7.33.
Patheon N.V. is a provider of outsourced pharmaceutical development and manufacturing services. The Company’s segments include Drug Product Services (DPS), Pharmaceutical Development Services (PDS) and Drug Substance Services (DSS). The DPS segment is engaged in manufacturing and packaging for approved prescription, over-the-counter (OTC) and nutritional products.
Receive News & Ratings for Patheon N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Patheon N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.